Featured Post
Why Automation Is Growing in Non-Sterile Compounding in the USA
Non-sterile compounding automation is reshaping how independent pharmacies in the United States operate. Driven by a convergence of regulatory demands, workforce constraints, and rising patient demand for personalized dosing, compounding pharmacy automation has moved from a niche consideration to a strategic priority for private pharmacies looking to remain competitive and compliant in 2026 and beyond.
Revolutionierung der pharmazeutischen Behandlung mit Hilfe neuer Technologien – Fallbeispiel iGalenici in Italien
Entdecken Sie, wie 3D-Drucktechnologie die pharmazeutische Behandlung revolutioniert. Am Beispiel iGalenici zeigen wir, wie personalisierte Medizin präzise Lösungen für Krebspatienten und seltene Krankheiten bietet.
Back to the Roots: This is Where It Started!
Niklas Sandler visits Åbo Akademi University in Turku to explore the origins of CurifyLabs' CSS technology and shares nostalgic insights and scientific revelations. Tune in for more!
We are excited to join #PediatRxCon34 from April 9th-12th
We are excited to participate in the #PediatRxCon34 in Portland from April 9th to 12th!
CurifyLabs on TV Again!
Our customer Johannes Wesling Klinikum in Minden was the topic of a television report, putting the light on the use of our Pharmaprinter at their hospital.
CurifyLabs is Honored to be Presenting at #APhA2025 in Nashville
CurifyLabs honored to be presenting at #APhA2025 in Nashville, March 21–24.
Revolutionizing pharmaceutical treatment with the help of new technologies - case iGalenici in Italy
Revolutionizing pharmaceutical treatment with the help of new technologies - case iGalenici in Italy
Live From Training the Helios Erfurt Pharmacy Team!
3D printed medicines Helios Erfurt Pharmacy automated compounding technology non-sterile
Press Release: Prinses Máxima Center Implements CurifyLabs' Compounding Technology to Advance Personalized Pediatric Treatments
Press Release: Prinses Máxima Center Implements CurifyLabs' Compounding Technology to Advance Personalized Pediatric Treatments
